Search research articles
Contact Us
Filters
Showing results (541-550 of 563) with videos related to
Page
of 57
Sort By:
Cancer
|
April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
International Journal of Nursing Sciences
|
February 27, 2020
Precision health: A nursing perspective
Mei R Fu, Emma Kurnat-Thoma, Angela Starkweather, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Scientific Reports
|
September 11, 2019
Neonicotinoid seed treatments of soybean provide negligible benefits to US farmers
Spyridon Mourtzinis, Christian H Krupke, Paul D Esker, et al.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Nature Biomedical Engineering
|
September 7, 2023
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses
Andrew C Tremain, Rachel P Wallace, Kristen M Lorentz, et al.
Human Molecular Genetics
|
July 1, 2005
Meta-analysis of genome scans of age-related macular degeneration
Sheila A Fisher, Goncalo R Abecasis, Beverly M Yashar, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 563) with videos related to
Sort By:
Page
of 57
Cancer
|
April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
International Journal of Nursing Sciences
|
February 27, 2020
Precision health: A nursing perspective
Mei R Fu, Emma Kurnat-Thoma, Angela Starkweather, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Scientific Reports
|
September 11, 2019
Neonicotinoid seed treatments of soybean provide negligible benefits to US farmers
Spyridon Mourtzinis, Christian H Krupke, Paul D Esker, et al.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Nature Biomedical Engineering
|
September 7, 2023
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses
Andrew C Tremain, Rachel P Wallace, Kristen M Lorentz, et al.
Human Molecular Genetics
|
July 1, 2005
Meta-analysis of genome scans of age-related macular degeneration
Sheila A Fisher, Goncalo R Abecasis, Beverly M Yashar, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Page
of 57